Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published online June 13 in Nature ...
Jun 26, 2025
0
0
Type 2 diabetes patients taking semaglutide, often sold as Ozempic or Wegovy, have a slightly lower risk of stroke compared to patients taking another diabetes drug—empagliflozin. International researchers studied data ...
Jun 17, 2025
0
1
SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there have been questions as to whether it is safe to use these drugs in patients after a recent heart ...
Jun 13, 2025
0
16
Researchers from the Germans Trias i Pujol research institute (IGTP) have conducted a preclinical study on the effects of the drug empagliflozin, alone or in combination with sacubitril/valsartan, in the early phase following ...
Jun 11, 2025
0
1
A team led by the University of Sydney has identified red blood cell rupture at dying endothelial sites as a primary driver of microvascular obstruction in COVID-19, bypassing the expected role of fibrin and platelet clots.
A "substantial number" of dementia cases in the U.S. could be eliminated by reducing cardiometabolic conditions such as heart attack, stroke and diabetes, according to a new study from Barrow Neurological Institute in Phoenix.
May 24, 2025
0
1
Researchers have found that prescribing guideline-directed medical treatment (GDMT), regardless of the number of medications, can improve survival rates in patients 90 years of age and older following their first heart attack, ...
May 22, 2025
0
0
The Family Heart Foundation, a leading research and advocacy organization focused on the role of lipids in cardiovascular disease and prevention, today announced results from the largest study ever conducted of people living ...
May 7, 2025
1
127
In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% experienced worse outcomes, including care escalation, CS deterioration, ...
May 1, 2025
0
0
The first study evaluating Medicare patients undergoing percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs) demonstrated good safety outcomes, such as mortality and adverse event rates at 30 days, ...
May 1, 2025
0
0
